Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,352 Cr
up ₹33.7 Cr vs Feb 2024
- Stocks held
- 26
- unchanged
- Top 10 weight
- 69.2%
- of the portfolio in its ten largest
- Cash & debt
- 1.7%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 14
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In March 2024 it disclosed 26 stocks worth ₹2,352 Cr, up ₹33.7 Cr from Feb 2024. Its largest positions were Sun Pharmaceutical Industries Limited (14.0%), IPCA Laboratories Limited (8.4%), Suven Pharmaceuticals Limited (8.3%); the ten largest together made up 69.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 71.3% of its equity. Cash and debt stood at 1.7%. Compared with Feb 2024 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
25%
Holds more cash than 25% of peers
What these mean: concentration · cash
Holdings in March 2024
Download CSVEvery line the fund disclosed, with the change against Feb 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 14.04% | up 0.17 pts | ₹330 Cr | up ₹8.7 Cr | Added |
| IPCA Laboratories Limited | 8.44% | up 0.43 pts | ₹198 Cr | up ₹12.8 Cr | Added |
| Suven Pharmaceuticals Limited | 8.33% | up 0.73 pts | ₹196 Cr | up ₹19.7 Cr | Added |
| Cipla Limited | 8.17% | down 0.03 pts | ₹192 Cr | up ₹2.1 Cr | Added |
| Lupin Limited | 7.51% | down 0.13 pts | ₹177 Cr | down ₹46 L | Held |
| Alembic Pharmaceuticals Limited | 5.93% | down 0.01 pts | ₹139 Cr | up ₹1.8 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.03% | up 0.13 pts | ₹118 Cr | up ₹4.8 Cr | Added |
| Globus Medical Inc | 4.22% | down 0.07 pts | ₹99.3 Cr | down ₹11 L | Held |
| Concord Biotech Limited | 4.04% | up 0.12 pts | ₹95 Cr | up ₹4 Cr | Added |
| Zydus Lifesciences Limited | 3.54% | up 0.18 pts | ₹83.3 Cr | up ₹5.4 Cr | Added |
| Procter & Gamble Health Limited | 3.18% | down 0.31 pts | ₹74.7 Cr | down ₹6 Cr | Trimmed |
| Alkem Laboratories Limited | 3.06% | down 0.16 pts | ₹72 Cr | down ₹2.7 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 2.76% | down 0.07 pts | ₹64.9 Cr | down ₹81 L | Trimmed |
| Intuitive Surgical Inc | 2.65% | up 0.07 pts | ₹62.4 Cr | up ₹2.4 Cr | Added |
| Kovai Medical Center and Hospital Limited | 2.63% | down 0.18 pts | ₹61.8 Cr | down ₹3.3 Cr | Trimmed |
| Indoco Remedies Limited | 2.36% | down 0.18 pts | ₹55.6 Cr | down ₹3.5 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 1.73% | down 0.05 pts | ₹40.7 Cr | down ₹66 L | Trimmed |
| Cash, TREPS & receivables | 1.70% | down 0.16 pts | ₹40.1 Cr | down ₹3.2 Cr | Trimmed |
| Narayana Hrudayalaya Limited | 1.63% | up 0.17 pts | ₹38.2 Cr | up ₹4.5 Cr | Added |
| Unichem Laboratories Limited | 1.54% | down 0.11 pts | ₹36.2 Cr | down ₹2 Cr | Trimmed |
| Aarti Drugs Limited | 1.36% | down 0.22 pts | ₹32 Cr | down ₹4.7 Cr | Trimmed |
| Taro Pharmaceutical Industries Limited | 1.34% | down <0.01 pts | ₹31.6 Cr | up ₹37 L | Added |
| Abbott Laboratories | 1.27% | down 0.07 pts | ₹29.9 Cr | down ₹1.1 Cr | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.04% | down 0.07 pts | ₹24.6 Cr | down ₹1.2 Cr | Trimmed |
| Illumina Inc | 0.99% | down 0.03 pts | ₹23.4 Cr | down ₹30 L | Trimmed |
| MedPlus Health Services Limited | 0.56% | down 0.02 pts | ₹13.2 Cr | down ₹16 L | Trimmed |
| Jupiter Life Line Hospitals Limited | 0.49% | down 0.08 pts | ₹11.5 Cr | down ₹1.8 Cr | Trimmed |
| Pfizer Limited | 0.45% | down 0.05 pts | ₹10.6 Cr | down ₹1 Cr | Trimmed |
What changed, Feb 2024 to Mar 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹19.7 Cr (+0.73% pts)
- IPCA Laboratories Limitedup ₹12.8 Cr (+0.43% pts)
- Sun Pharmaceutical Industries Limitedup ₹8.7 Cr (+0.17% pts)
- Zydus Lifesciences Limitedup ₹5.4 Cr (+0.18% pts)
- Apollo Hospitals Enterprise Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.6 pts), and fell most in Pharmaceuticals (−0.4 pts).
- Pharmaceuticals & Biotechnology70.8% → 71.3%+0.6 pts
- Pharmaceuticals5.7% → 5.3%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2021 | Mar 2023 | Sep 2023 | Dec 2023 | Feb 2024 | Mar 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 64.2% | 69.9% | 73.1% | 71.8% | 70.8% | 71.3% |
| Healthcare Services | 22.2% | 15.2% | 11.7% | 12.4% | 14.0% | 13.9% |
| Healthcare Equipment & Supplies | 3.2% | 6.0% | 6.9% | 7.6% | 7.1% | 7.1% |
| Pharmaceuticals | 7.1% | 5.7% | 5.5% | 5.7% | 5.7% | 5.3% |
| Insurance | 3.3% | 2.2% | 1.9% | 1.7% | 1.8% | 1.8% |
| Retailing | — | 1.1% | 0.9% | 0.7% | 0.6% | 0.6% |
Allocation in Mar 2024change vs Feb 2024
- Pharmaceuticals & Biotechnology (13)71.3%▲ 0.6 pts
- Healthcare Services (6)13.9%▼ 0.1 pts
- Healthcare Equipment & Supplies (2)7.1%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Mar 2024
1.7%
▼ 0.2 pts vs Feb 2024
- Cash alone
- 1.7%
- cash and net receivables
- A year earlier
- <0.1%
- Mar 2023 · now ▲ 1.7 pts
- Last 12 months
- 0.2% – 3.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.